Objectives: The objective of the third term of Health Japan 21 is to “extend healthy life expectancy and reduce health inequalities.” Health maintenance and promotion measures must be implemented continuously and systematically from a medium- to long-term perspective. Therefore, it is important to promote measures in accordance with the Plan-Do-Check-Act (PDCA) cycle. To foster effective and efficient community health promotion and the PDCA cycle of health activities, project evaluations were introduced into activities of the National Health Insurance Insurer Effort Support System. However, what types of activities are related to a healthy life expectancy remain unclear. Therefore, this study clarified the relationship between each project evaluation score and changes in healthy life expectancy. Methods: This study used a regional correlation method with a longitudinal design and analyzed 1,147 municipalities, excluding those with a population of less than 12,000 (in 2021) and where the error in the calculation of healthy life expectancy was large. The percentage was calculated using the annual project evaluation scores submitted by the municipalities to the Ministry of Health, Labour and Welfare, based on the project evaluation of the system for 2017–2021. Healthy life expectancy of municipal populations was represented by the average healthy period at 65 years and was calculated for each gender using the “period during which people are independent in daily living activities”; a nursing care requirement of 2 or above denoted an unhealthy period. This calculation was based on the “the period during which people can live without being restricted in their daily lives by health problems” in Health Japan 21. Multiple regression analysis was conducted using each project evaluation score as an explanatory variable and the logarithm of healthy life expectancy, taxable income, and density of inhabitable land as adjustment variables for 2017. Results: For both men and women, the rates of specified health checkups, specified health guidance, and reduction in the number of persons with metabolic syndrome and pre-metabolic syndrome (men: β=0.153, p<0.001; women: β=0.087, p=0.003), promotion of community comprehensive care (men: β=0.059, p=0.043; women: β=0.065, p=0.020), and third-party reimbursement (male: β=0.059, p=0.041, female: β=0.067, p=0.017). Further, the higher the project evaluation score, the longer the healthy life expectancy. Conclusion: The project evaluation scores for the rates of specified health checkups, specified health guidance, reduction in the number of persons with metabolic syndrome and pre-metabolic syndrome, promotion of community-based comprehensive care, and third-party reimbursement were associated with the promotion of healthy life expectancy. These projects are easily adapted to PDCA and may contribute to the extension of healthy life expectancy."
View full abstract